CICONTE, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 2.521
EU - Europa 2.218
AS - Asia 1.925
SA - Sud America 494
Continente sconosciuto - Info sul continente non disponibili 244
AF - Africa 55
Totale 7.457
Nazione #
US - Stati Uniti d'America 2.350
RU - Federazione Russa 1.113
SG - Singapore 724
IT - Italia 542
CN - Cina 532
BR - Brasile 397
HK - Hong Kong 227
VN - Vietnam 194
SE - Svezia 165
DE - Germania 82
FR - Francia 81
CA - Canada 80
GB - Regno Unito 59
BD - Bangladesh 48
FI - Finlandia 46
IN - India 40
AR - Argentina 34
MX - Messico 29
IE - Irlanda 24
ID - Indonesia 22
JP - Giappone 21
NL - Olanda 21
AT - Austria 19
ZA - Sudafrica 19
IQ - Iraq 18
PL - Polonia 18
EC - Ecuador 16
TR - Turchia 15
CO - Colombia 14
CR - Costa Rica 12
PK - Pakistan 12
LT - Lituania 11
JM - Giamaica 10
MA - Marocco 9
PY - Paraguay 9
ES - Italia 8
KE - Kenya 8
OM - Oman 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
BE - Belgio 7
CL - Cile 7
MD - Moldavia 7
VE - Venezuela 7
PH - Filippine 6
TT - Trinidad e Tobago 6
EG - Egitto 5
GT - Guatemala 5
HN - Honduras 5
NI - Nicaragua 5
NP - Nepal 5
DO - Repubblica Dominicana 4
IR - Iran 4
JO - Giordania 4
MY - Malesia 4
SV - El Salvador 4
TN - Tunisia 4
UY - Uruguay 4
UZ - Uzbekistan 4
AZ - Azerbaigian 3
BH - Bahrain 3
BO - Bolivia 3
EU - Europa 3
LB - Libano 3
PE - Perù 3
PT - Portogallo 3
RO - Romania 3
SN - Senegal 3
UA - Ucraina 3
BB - Barbados 2
DZ - Algeria 2
GP - Guadalupe 2
KZ - Kazakistan 2
PR - Porto Rico 2
QA - Qatar 2
AL - Albania 1
AM - Armenia 1
AW - Aruba 1
BM - Bermuda 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
GE - Georgia 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
ME - Montenegro 1
MN - Mongolia 1
MU - Mauritius 1
TG - Togo 1
TH - Thailandia 1
TL - Timor Orientale 1
TZ - Tanzania 1
VG - Isole Vergini Britanniche 1
Totale 7.216
Città #
Singapore 311
San Jose 310
Ashburn 298
Moscow 230
Hong Kong 226
Dallas 185
Council Bluffs 161
Milan 129
Shanghai 99
Hefei 83
Santa Clara 74
Beijing 73
Ho Chi Minh City 71
Lauterbourg 70
Phoenix 66
Lawrence 65
Princeton 63
New York 60
Rome 52
Los Angeles 39
Hanoi 35
São Paulo 34
Helsinki 32
Orem 28
Dublin 23
Toronto 22
London 21
Atlanta 20
Montreal 20
Naples 20
Brooklyn 17
Chicago 17
Nuremberg 17
Tokyo 17
Chennai 16
Warsaw 16
Denver 15
Frankfurt am Main 14
Boardman 13
San Francisco 13
Amsterdam 12
Seattle 12
Vienna 12
Cesano Boscone 11
Haiphong 11
Las Vegas 11
Brasília 10
Mexico City 10
Rio de Janeiro 10
Turin 10
Biên Hòa 9
Johannesburg 9
Miano 9
Baghdad 8
Florence 8
Manchester 8
Munich 8
Philadelphia 8
San José 8
Stockholm 8
Ankara 7
Brescia 7
Falkenstein 7
Genoa 7
Nairobi 7
Omaha 7
Palermo 7
Queens 7
Turku 7
Belo Horizonte 6
Bologna 6
Buenos Aires 6
Curitiba 6
Guangzhou 6
Lappeenranta 6
Miami 6
Monza 6
Muscat 6
Quito 6
Recife 6
Salvador 6
The Bronx 6
Asunción 5
Boston 5
Cagliari 5
Catania 5
Da Nang 5
Ferrara 5
Goiânia 5
Guarulhos 5
Hangzhou 5
Houston 5
Jacksonville 5
Jakarta 5
Kassel 5
Managua 5
Memphis 5
Mumbai 5
Poplar 5
Santiago 5
Totale 3.498
Nome #
Arrhythmogenic substrate elimination for safe testosterone therapy in symptomatic Brugada syndrome patients 268
Unravelling Novel SCN5A Mutations Linked to Brugada Syndrome: Functional, Structural, and Genetic Insights 149
Brugada Syndrome: New Insights From Cardiac Magnetic Resonance and Electroanatomical Imaging 149
Challenges in Brugada Syndrome Stratification: Investigating SCN5A Mutation Localization and Clinical Phenotypes 138
Brugada syndrome genetics is associated with phenotype severity 128
Cell-Based Therapies for Cardiac Regeneration: A Comprehensive Review of Past and Ongoing Strategies 127
Human Sarcopenic Myoblasts Can Be Rescued by Pharmacological Reactivation of HIF-1α 124
Clinical characteristics and electrophysiologic properties of SCN5A variants in fever-induced Brugada syndrome 121
Brugada Syndrome: Warning of a Systemic Condition? 117
Ebstein's anomaly in children and adults: Multidisciplinary insights into imaging and therapy 116
Analysis of the intramolecular 1,7-lactone of N-acetylneuraminic acid using HPLC–MS: relationship between detection and stability 115
Second-generation laser balloon ablation for the treatment of atrial fibrillation assessed by continuous rhythm monitoring: the LIGHT-AF study 115
Atrial fibrillation in autoimmune rheumatic diseases: From pathogenesis to treatment 111
GM1 Ganglioside Promotes Osteogenic Differentiation of Human Tendon Stem Cells 107
Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation 106
Atrial fibrillation detection using a novel three-vector cardiac implantable monitor: The atrial fibrillation detect study 106
Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants 103
HIF-1α Directly Controls WNT7A Expression During Myogenesis 101
Clinical considerations for a family with dilated cardiomyopathy, sudden cardiac death, and a novel ttn frameshift mutation 100
Neu3 Sialidase Activates the RISK Cardioprotective Signaling Pathway during Ischemia and Reperfusion Injury (IRI) 98
Atrial fibrillation recurrences during the blanking period after catheter ablation with the laser balloon technique 95
Brugada Syndrome: Oligogenic or Mendelian Disease? 89
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implications 88
Left Atrial Dynamics During Exercise in Mitral Regurgitation of Primary and Secondary Origin: Pathophysiological Insights by Exercise Echocardiography Combined With Gas Exchange Analysis 88
Genotype/Phenotype Relationship in a Consanguineal Family With Brugada Syndrome Harboring the R1632C Missense Variant in the SCN5A Gene 87
Deep learning unmasks the ECG signature of Brugada syndrome 82
Clinical outcome of electrophysiologically guided ablation for nonparoxysmal atrial fibrillation using a novel real-time 3-dimensional mapping technique results from a prospective randomized trial 82
Intermittent alternance of Brugada ECG patterns: Insights from a unique electrophysiological phenomenon 82
Electrical Substrate Elimination in 135 Consecutive Patients with Brugada Syndrome 82
Asymptomatic ventricular preexcitation: a long-term prospective follow-up study of 293 adult patients 80
Atrial fibrillation progression and management: a 5-year prospective follow-up study 80
Novel scn5a p.V1429m variant segregation in a family with brugada syndrome 80
Electrocardiographic temporo-spatial assessment of depolarization and repolarization changes after epicardial arrhythmogenic substrate ablation in Brugada syndrome 79
Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death 79
Novel scn5a p.Val1667asp missense variant segregation and characterization in a family with severe brugada syndrome and multiple sudden deaths 79
Regenerating the human heart : direct reprogramming strategies and their current limitations 77
Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen 77
Commentary: Next generation sequencing and linkage analysis for the molecular diagnosis of a novel overlapping syndrome characterized by hypertrophic cardiomyopathy and typical electrical instability of brugada syndrome 76
Assessing the Malignant Ventricular Arrhythmic Substrate in Patients With Brugada Syndrome 74
Epicardial arrhythmogenic substrate in long QT syndrome 72
New electromechanical substrate abnormalities in high-risk patients with Brugada syndrome 72
Congenital coronary artery anomalies: Differential diagnosis of ventricular arrhythmias in young athletes 71
Non-invasive assessment of the arrhythmogenic substrate in Brugada syndrome using signal-averaged electrocardiogram: Clinical implications from a prospective clinical trial 70
General Anesthesia Attenuates Brugada Syndrome Phenotype Expression: Clinical Implications From a Prospective Clinical Trial 70
Genotype-Phenotype Correlation in a Family with Brugada Syndrome Harboring the Novel p.Gln371* Nonsense Variant in the SCN5A Gene 68
SCN5A nonsense mutation and NF1 frameshift mutation in a family with brugada syndrome and neurofibromatosis 66
Unusual response to ajmaline test in Brugada syndrome patient leads to extracorporeal membrane oxygenator support 66
Feasibility of Remote Monitoring Using a Novel Long-Dipole Insertable Cardiac Monitor 66
Long-term outcome of remote catheter ablation using a magnetic irrigated-tip catheter 65
The natural history of asymptomatic ventricular pre-excitation a long-term prospective follow-up study of 184 asymptomatic children 65
Multipoint pacing improves peripheral hemodynamic response: Noninvasive assessment using radial artery tonometry 63
Out-of-hospital cardiac arrest due to idiopathic ventricular fibrillation in patients with normal electrocardiograms: Results from a multicentre long-term registry 61
New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: Prevalence and clinical significance 60
Safety and feasibility of a novel multielectrode array catheter in mapping atrial and ventricular arrhythmias with high density: results from the multicenter OPTIMUM study 59
Novel SCN5A Frameshift Mutation in Brugada Syndrome Associated With Complex Arrhythmic Phenotype 59
Safety and efficacy of circumferential pulmonary vein ablation in octogenarians with atrial fibrillation 59
Novel scn5a p.W697x nonsense mutation segregation in a family with brugada syndrome 59
Thrombosis on a left atrial appendage occluder device: The double-edged sword of stroke prevention strategies in atrial fibrillation 59
Atrial Fibrillation Progression in Patients With and Without Lone Atrial Fibrillation: A Five-Year Prospective Follow-Up Study 58
Role of sialidase Neu3 and ganglioside GM3 in cardiac fibroblasts activation 58
AF ablation in the elderly population. The Milan experience 57
Multipoint left ventricular pacing improves response to cardiac resynchronization therapy with and without pressure-volume loop optimization: comparison of the long-term efficacy of two different programming strategies 57
Reversine: A Synthetic Purine with a Dual Activity as a Cell Dedifferentiating Agent and a Selective Anticancer Drug 56
Early rhythm control strategy by catheter ablation in patients with paroxysmal atrial fibrillation: the 4-year results of a randomized follow-up study comparing catheter ablation and antiarrhythmic drug therapy: The APAF 2 Study 55
Remote irrigated-tip ablation. The first human experience in patients with WPW syndrome 55
Novel CineECG Derived from Standard 12-Lead ECG Enables Right Ventricle Outflow Tract Localization of Electrical Substrate in Patients with Brugada Syndrome 55
Long-term outcome benefits of catheter ablation versus antiarrhythmic drug therapy. A prospective, randomized two year extension study, the APAF 2 Study 54
The role of implantable cardiac monitors in atrial fibrillation management 54
Right ventricular electromechanical abnormalities in Brugada syndrome: is this a cardiomyopathy? 53
New-Onset Atrial Fibrillation as the First Clinical Manifestation of Latent Brugada Syndrome: Incidence and Clinical Significance 53
The natural history of ventricular preexcitation in 293 asymptomatic adult subjects 52
Common modulators of Brugada syndrome phenotype do not affect SCN5A prognostic value 50
Catheter ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation. A Long-term Randomized Follow-up Study. The APAF2 Study 50
Circumferential Pulmonary Vein Ablation Using a Remote Irrigated Tip Magnetic Catheter: Long-Term Outcome 50
First human experience with an irrigated tip catheter for remote circumferential pulmonary vein ablation. Preliminary results in 33 patients with atrial fibrillation 49
Lone atrial fibrillation as the first clinical manifestation of a latent Brugada syndrome 47
Epicardial ablation in genetic cardiomyopathies: A new frontier 47
Catheter ablation versus antiarrhythmic drug therapy. A prospective, randomized, long-term study. The APAF 2 46
Non-paroxysmal atrial fibrillation mapping: characterization of the electrophysiological substrate using a novel integrated mapping technique 46
Safety, Efficacy and Follow-Up of Circumferential Pulmonary Vein Ablation in Octogenarians 45
Predictors of sudden death in patients with Wolff-Parkinson-White Syndrome. A prospective follow-up study of 201 symptomatic WPW patients presenting with malignant arrhythmias 45
The First Human Experience With An Irrigated-tip Magnetic Catheter In Patients Undergoing Remote Ablation Of Atrial Fibrillation 44
Semaglutide as adjunctive therapy to catheter ablation in obesity-related paroxysmal atrial fibrillation 25
Ablation of the epicardial substrate in patients with long-QT syndrome at risk of sudden death 23
Structural characterization of atrial natriuretic peptide amyloid fibrils from patients with atrial fibrillation 23
The HIF-1α Pathway Regulates Satellite Cell Fate During Aging Through Histone Lactylation 22
The “arrhythmic” presentation of peripartum cardiomyopathy: case series and critical review of the literature 21
Complications in the setting of percutaneous atrial fibrillation ablation using radiofrequency and cryoballoon techniques: A single-center study in a large cohort of patients 19
Beta-Blockers after Myocardial Infarction 19
Mode and Characteristics of Arrhythmia Initiation in Idiopathic Ventricular Fibrillation: A THESIS Substudy 19
Anatomical-guided third-generation laser balloon ablation for the treatment of paroxysmal atrial fibrillation assessed by continuous rhythm monitoring: results from a multicentre prospective study 18
High-risk Brugada syndrome: Factors associated with arrhythmia recurrence and benefits of epicardial ablation in addition to implantable cardioverter defibrillator implantation 18
The clinical impact of ajmaline challenge in elderly patients with suspected atrioventricular conduction disease 17
Ventricular fibrillation ablation in cardiomyopathies and arrhythmic storm 17
Left bundle branch area pacing vs. right ventricular pacing in post-transcatheter aortic valve implantation patients: a retrospective propensity-matched analysis 17
AI-Assisted 3D Intracardiac Echocardiography for Pulsed Field Ablation of Atrial Fibrillation Using a Novel Variable Loop Circular Catheter: A Multicenter Evaluation 17
Atrial fibrillation laser balloon ablation: Multicenter international study 17
Midterm clinical outcomes of concomitant thoracoscopic epicardial and transcatheter endocardial ablation for persistent and long-standing persistent atrial fibrillation: a single-centre experience 16
The Electro-Anatomical Pathway for Normal and Abnormal ECGs in COVID Patients 16
Multielectrode Radiofrequency Balloon Catheter for Paroxysmal Atrial Fibrillation: Results From the Global, Multicenter, STELLAR Study 16
Totale 6.861
Categoria #
all - tutte 44.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.364


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202242 0 0 0 13 4 2 15 1 6 0 0 1
2022/2023360 160 68 19 7 2 41 22 13 21 5 2 0
2023/2024155 2 4 14 44 12 14 5 15 0 6 13 26
2024/20251.239 174 47 7 34 58 88 150 132 208 154 74 113
2025/20263.939 237 304 299 572 290 101 324 250 1.016 220 194 132
2026/20271.655 341 492 397 425 0 0 0 0 0 0 0 0
Totale 7.457